Omega Diagnostics Group
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Omega Diagnostics Group generated cash of -$3,152,000, which is less than the previous year. Cash used in financing activities reached the amount of $1,486,000 last year. Net change in cash is therefore $3,510,000.
Cash Flow
| 2010 | 170K | -668K | 564K |
|---|---|---|---|
| 2011 | 322K | -5.67M | 6.70M |
| 2012 | 673K | -1.19M | -333K |
| 2016 | 1.45M | -2.02M | -166.67K |
| 2018 | -828.49K | -3.27M | 3.48M |
| 2020 | 547.60K | -2.15M | 1.63M |
| 2021 | -2.41M | -2.82M | 11.07M |
| 2023 | -3.15M | 5.18M | 1.48M |
ODX.L Cash Flow Statement (2010 – 2022)
| 2022 | 2020 | 2019 | 2017 | 2015 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 1.60M | 0 | 0 | 737.33K | 1.97M | 2.05M | 679K | 613K |
Operating activities | ||||||||
Net income | -3.86M | -2.10M | -6.82M | -7.26M | 571.91K | 527K | 31K | 187K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||
Depreciation and amortization | 591K | 886.40K | 1.15M | 624.57K | 631.73K | 680K | 337K | 212K |
Stock-based compensation expense | 78K | 270.26K | 54.09K | 52.27K | 362.32K | 30K | 8K | 178K |
| Deferred income tax benefit | 78K | 270.26K | 54.09K | 52.27K | 362.32K | 30K | 8K | 178K |
| Changes in operating assets and liabilities: | ||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 128K | -1.06M | -168.41K | 553.61K | 50.6K | -187K | 96K | -49K |
Accounts payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | -3.15M | -2.41M | 547.60K | -828.49K | 1.45M | 673K | 322K | 170K |
Investing activities | ||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -153K | -2.82M | -2.15M | -3.27M | -2.03M | -1.22M | -764K | -90K |
Acquisitions Net | 5.31M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 5.18M | -2.82M | -2.15M | -3.27M | -2.02M | -1.19M | -5.67M | -668K |
Financing activities | ||||||||
Common Stock Issued | 2.2M | 11.85M | 2.34M | 3.26M | 0 | 0 | 7.75M | 919K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -565.16K | 0 | 0 | 0 | -273K | -277K | -273K |
Cash used in financing activities | 1.48M | 11.07M | 1.63M | 3.48M | -166.67K | -333K | 6.70M | 564K |
Net Change In Cash | 3.51M | 5.82M | 0 | -621.61K | -669.88K | -896K | 1.37M | 66K |
Cash at end of period | 5.11M | 5.82M | 0 | 115.71K | 1.30M | 1.15M | 2.05M | 679K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |